The Board of Trustees of the Leland Stanford
Junior University
发明人:
申请号：
EP21176474.1
公开号：
EP3936143A1
申请日:
2016.05.23
申请国别(地区):
EP
年份:
2022
代理人:
摘要：
Compositions and methods for treating hyperinsulinemic hypoglycemia, such as hyperinsulinemic hypoglycemia after bariatric surgery, are provided. In some embodiments, an effective amount of the glucagon-like peptide-1 receptor antagonist exendin(9-39) is subcutaneously administered twice per day.
